Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee

A. Compostella, M.C. Affinita, M. Casanova, G.M. Milano, A. Scagnellato, P. Dall’Igna, S. Chiaravalli, M. Pierobon, C. Manzitti, I. Zanetti, A. Schiavetti, S. Sorbara, R.M. Mura, A. Ruggiero, A. Ferrari, G. Bisogno

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)138-143
Number of pages6
JournalTumori
Volume105
Issue number2
DOIs
Publication statusPublished - 2019

Cite this

Compostella, A., Affinita, M. C., Casanova, M., Milano, G. M., Scagnellato, A., Dall’Igna, P., Chiaravalli, S., Pierobon, M., Manzitti, C., Zanetti, I., Schiavetti, A., Sorbara, S., Mura, R. M., Ruggiero, A., Ferrari, A., & Bisogno, G. (2019). Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee. Tumori, 105(2), 138-143. https://doi.org/10.1177/0300891618792479